Clinical trial Recruiting at 1 site Observational Ages 18 and up

Bedside saline-contrast electrical impedance tomography for diagnosing acute pulmonary embolism

Official title: A Multicenter Comparative Study of Saline Contrast Electrical Impedance Tomography Method Versus CTPA in the Diagnosis of Acute Pulmonary Embolism

Run by Peking Union Medical College Hospital · NCT07190079 · Data updated 2026-11-12

This study will test whether a bedside saline-contrast electrical impedance tomography (EIT) scan can diagnose acute pulmonary embolism in adults with suspected PE and respiratory failure.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment343 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedSeptember 24, 2025
Main results expectedMay 1, 2027
Study endsSeptember 15, 2027
Registry record updatedOctober 2, 2025
Trial IDNCT07190079 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with suspected or confirmed acute pulmonary embolism presenting with acute respiratory failure, who have venous access and can undergo CTPA within 24 hours, are ideal candidates.

Probably not a fit

Patients who are pregnant or lactating, have pacemakers or chest wall wounds at electrode sites, severe hypernatremia, BMI over 50, are on ECMO, or cannot hold their breath for the required time are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares a bedside saline-contrast electrical impedance tomography (EIT) method with standard computed tomography pulmonary angiography (CTPA) for diagnosing acute pulmonary embolism. Patients with suspected or confirmed acute PE and acute respiratory failure will undergo both saline-contrast EIT and CTPA within 24 hours. The EIT procedure uses a short saline bolus injected through central or peripheral venous access while an electrode belt measures impedance changes to map lung perfusion. Study findings will compare EIT and CTPA results for consistency to determine whether EIT reliably detects perfusion defects consistent with PE.

Why it matters

Potential benefit: If successful, this could enable faster bedside detection of PE in unstable patients, reducing the need to move critically ill patients for CT and lowering radiation exposure.

How similar studies have gone: Some small pilot studies have shown that saline-contrast EIT can map pulmonary perfusion, but it remains incompletely validated against CTPA and is not yet widely adopted.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure;
2. Availability of CTPA results within 24 hours or scheduled to undergo CTPA within the next 24 hours;
3. Age \>18 years; no gender restrictions;
4. Presence of central venous access (internal jugular or subclavian vein) or peripheral forearm venous access;
5. Willingness to participate with signed informed consent from either the patient or legal guardian.

Exclusion Criteria:

1. Pregnancy or lactation;
2. Relative contraindications to EIT examination (e.g., chest wall wounds at electrode belt placement site, presence of pacemakers);
3. Severe hypernatremia (serum sodium \>155 mmol/L);
4. Inability to maintain expiratory breath-hold for ≥8 seconds;
5. BMI \>50 or severe thoracic deformities;
6. Current extracorporeal membrane oxygenation (ECMO) therapy.

Where it's running

  • Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.